share_log

Insider Sale: Director at $PEBK (PEBK) Sells 1,000 Shares

Quiver Quantitative ·  Nov 26 02:45

JAMES S ABERNETHY, a director at $PEBK ($PEBK), sold 1,000 shares of the company on 11-22-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.3% of their shares. Following this trade, they now own 73,976 shares of $PEBK stock.

$PEBK Insider Trading Activity

$PEBK insiders have traded $PEBK stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here's a breakdown of recent trading of $PEBK stock by insiders over the last 6 months:

  • JAMES S ABERNETHY has traded it 9 times. They made 0 purchases and 9 sales, selling 9,000 shares.
  • KIM BOYD-LEAKS sold 8,686 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$PEBK Hedge Fund Activity

We have seen 38 institutional investors add shares of $PEBK stock to their portfolio, and 17 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • FOURTHSTONE LLC removed 344,659 shares (-94.5%) from their portfolio in Q3 2024
  • BLACKROCK, INC. added 86,309 shares (+34.3%) to their portfolio in Q3 2024
  • ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 54,966 shares (+763.3%) to their portfolio in Q3 2024
  • CITADEL ADVISORS LLC added 32,739 shares (+inf%) to their portfolio in Q3 2024
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 31,590 shares (-100.0%) from their portfolio in Q2 2024
  • RENAISSANCE TECHNOLOGIES LLC added 27,395 shares (+124.5%) to their portfolio in Q3 2024
  • STRATEGIC VALUE BANK PARTNERS LLC removed 24,462 shares (-8.2%) from their portfolio in Q3 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment